BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $125

Benzinga · 3d ago
BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $134 to $125.